Welcome to our dedicated page for Cannabist SEC filings (Ticker: CBSTF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cannabist Company Holdings Inc. (CBSTF) files a range of reports and disclosures with the U.S. Securities and Exchange Commission that shed light on its cannabis operations, capital structure and governance. As a British Columbia corporation with U.S. reporting obligations, its SEC filings help investors understand how the company manages its multi-state cultivation, manufacturing and retail footprint.
On this page, you can review current and historical SEC filings for The Cannabist Company, including Form 8-K reports detailing material events. Recent 8-K filings describe equity purchase agreements to sell the company’s Virginia subsidiary, Green Leaf Medical of Virginia, LLC, first to Curaleaf, Inc. and later to an entity affiliated with Millstreet Credit Fund LP, along with the termination of the Curaleaf agreement and related break-up fee. Other 8-Ks discuss the formation of a special committee to review strategic alternatives, the election not to make an interest payment on senior secured notes within the initial due date, and the resulting 30-day grace period under the indenture.
Filings also cover governance and compensation matters, such as board election results at the annual general meeting, the resignation of a co-founder from the Board of Directors, the transition of the Chief Financial Officer to a consulting role, and the adoption of a key employee retention bonus program that replaced a prior transaction bonus plan. These documents provide context on how the company is addressing leadership continuity and retention during its strategic review.
In addition to event-driven 8-Ks, investors can access quarterly and annual reports referenced in the company’s press releases. These filings include discussions of revenue, margins, non-GAAP measures such as Adjusted EBITDA and Adjusted Gross Profit, and risk factors related to cannabis regulation, taxation and financing.
Stock Titan’s platform presents these filings with AI-powered summaries that highlight key terms, transaction structures, grace periods, and board or executive changes. Real-time updates from EDGAR, along with structured access to material contracts and event disclosures, help users quickly identify developments affecting The Cannabist Company’s notes, asset sales, governance and strategic alternatives.
The Cannabist Company Holdings Inc. is filing Post-Effective Amendments to terminate and deregister two Form S-3 registration statements. The amendments remove from registration any unsold securities originally registered under Registration Nos. 333-275821 (up to an aggregate offering price of $250,000,000) and 333-278472 (84,426,229 common shares). The company states that the offerings are being terminated in connection with a Companies’ Creditors Arrangement Act proceeding in Ontario commenced on March 24, 2026 and related Chapter 15 petitions filed in Delaware on March 25, 2026. Upon effectiveness of these amendments, no securities will remain registered under the Registration Statements.
The Cannabist Company Holdings Inc. is terminating its Form S-3 registration statements and deregistering all unsold securities registered thereunder.
The registrations covered up to an aggregate offering price of $250,000,000 under Registration No. 333-275821 and 84,426,229 shares of common stock under Registration No. 333-278472. The deregistration follows the commencement of CCAA proceedings in Ontario and voluntary Chapter 15 petitions filed in the U.S.
The Cannabist Company Holdings Inc. is filing Post-Effective Amendments to terminate and deregister all unsold common shares under its Form S-1 registration statements, including 18,755,082 and 33,366,315 common shares, as of the effectiveness of these amendments. The company cites commencement of a Canadian CCAA proceeding on March 24, 2026 and related Chapter 15 filings in the United States on March 25, 2026 as the context for terminating the offerings.
The Cannabist Company Holdings Inc. is filing post-effective amendments to terminate two Form S-1 registration statements and deregister all unsold common shares registered thereunder.
The filing identifies Registration No. 333-265095 which originally registered 18,755,082 common shares and Registration No. 333-275061 which originally registered 33,366,315 common shares (including 11,122,105 issuable upon exercise of warrants). The deregistration follows commencement of a Canadian restructuring under the CCAA on March 24, 2026 and Chapter 15 petitions filed on March 25, 2026; as of the effectiveness of these amendments, no securities remain registered under those registration statements.
The Cannabist Company Holdings Inc. has entered into binding deals to sell its Ohio and Delaware operations and begun court-supervised restructuring in Canada and the U.S. The Ohio business is being sold to Holistic Industries for $47 million, including $34.5 million in cash at closing and a $12.5 million promissory note, subject to adjustments. The Delaware assets are being sold to Parma Holdco for $16.5 million in cash, part of which will be held in escrow for indemnities.
The company has signed a support agreement with senior secured noteholders holding around 60% of its notes to back these transactions and additional sales, including operations in other states for at least $25 million in cash plus a $25 million note, while winding down remaining markets. Cannabist and a Canadian affiliate have commenced proceedings under the Companies’ Creditors Arrangement Act in Ontario and plan a related Chapter 15 case in the U.S. A court-appointed monitor will oversee the process, operations in New York have ceased, Pennsylvania is being wound down, and trading on Cboe Canada is expected to be halted with a potential delisting review.
The Cannabist Company Holdings Inc. entered into an amended forbearance arrangement with an ad hoc group of holders of its 9.25% Senior Secured Notes due December 31, 2028 and 9.00% Senior Secured Convertible Notes due December 31, 2028. The noteholders agreed to further extend their agreement to forbear from exercising rights and remedies under the governing indenture and applicable law until March 25, 2026, giving the company a short additional period of relief while it addresses its obligations under these secured notes.